Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Policy Analysis, commonly known as PAI, was a U.S.-based health economics and outcomes research (HEOR) consultancy serving pharmaceutical, biotechnology, medical device, and diagnostics clients. The company specialized in economic modeling, real-world data analytics, pharmacoepidemiology, quality-of-life assessment, health technology assessment, and value justification rather than developing therapeutic products. Founded in 1973 in the Boston area, PAI built a long operating history as an independent consultancy before being acquired by Avalere Health in 2022. Following the acquisition, the business was integrated into Avalere Health’s Policy, Access, Value, and Evidence organization, and PAI no longer appears to operate as a standalone active company brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Policy Analysis.